ES496749A0 - Procedimiento de preparacion de derivados de tetrahidronaf- taleno - Google Patents

Procedimiento de preparacion de derivados de tetrahidronaf- taleno

Info

Publication number
ES496749A0
ES496749A0 ES496749A ES496749A ES496749A0 ES 496749 A0 ES496749 A0 ES 496749A0 ES 496749 A ES496749 A ES 496749A ES 496749 A ES496749 A ES 496749A ES 496749 A0 ES496749 A0 ES 496749A0
Authority
ES
Spain
Prior art keywords
tetrahidronaf
talene
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES496749A
Other languages
English (en)
Other versions
ES8200860A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of ES496749A0 publication Critical patent/ES496749A0/es
Publication of ES8200860A1 publication Critical patent/ES8200860A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C07D303/26—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds having one or more free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
ES496749A 1979-11-13 1980-11-12 Procedimiento de preparacion de derivados de tetrahidronaf- taleno Expired ES8200860A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9365479A 1979-11-13 1979-11-13

Publications (2)

Publication Number Publication Date
ES496749A0 true ES496749A0 (es) 1981-11-16
ES8200860A1 ES8200860A1 (es) 1981-11-16

Family

ID=22240065

Family Applications (1)

Application Number Title Priority Date Filing Date
ES496749A Expired ES8200860A1 (es) 1979-11-13 1980-11-12 Procedimiento de preparacion de derivados de tetrahidronaf- taleno

Country Status (17)

Country Link
EP (1) EP0028940B1 (es)
JP (1) JPS5686140A (es)
AR (1) AR228579A1 (es)
AT (1) ATE4588T1 (es)
AU (1) AU543557B2 (es)
CA (1) CA1148152A (es)
DE (1) DE3064775D1 (es)
DK (1) DK482080A (es)
ES (1) ES8200860A1 (es)
GR (1) GR72294B (es)
HU (1) HU182233B (es)
IE (1) IE50341B1 (es)
IT (1) IT1218431B (es)
NO (1) NO152372C (es)
NZ (1) NZ195470A (es)
PT (1) PT72050B (es)
ZA (1) ZA806871B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787767A (fr) * 1971-08-21 1973-02-19 Merck Patent Gmbh Procede de preparation d'amides d'acides oxocarboxyliques et d'acides oxocarboxyliques
GB1559987A (en) * 1975-11-06 1980-01-30 Squibb & Sons Inc 1,2,3,4-tetrahydronaphthalene derivatives
AT350539B (de) * 1976-02-09 1979-06-11 Squibb & Sons Inc Verfahren zur herstellung von neuen 4-(3-subst. amino-2-hydroxpropoxy)-5,6,7,8-tetrahydro- 1,6,7-naphthalintriolen

Also Published As

Publication number Publication date
AR228579A1 (es) 1983-03-30
DE3064775D1 (en) 1983-10-13
JPS5686140A (en) 1981-07-13
EP0028940A1 (en) 1981-05-20
EP0028940B1 (en) 1983-09-07
GR72294B (es) 1983-10-18
HU182233B (en) 1983-12-28
NO803413L (no) 1981-05-14
CA1148152A (en) 1983-06-14
NO152372B (no) 1985-06-10
PT72050B (en) 1981-09-24
ES8200860A1 (es) 1981-11-16
NO152372C (no) 1985-09-18
DK482080A (da) 1981-05-14
NZ195470A (en) 1984-05-31
ATE4588T1 (de) 1983-09-15
AU543557B2 (en) 1985-04-26
IE50341B1 (en) 1986-04-02
PT72050A (en) 1980-12-01
IT1218431B (it) 1990-04-19
AU6413880A (en) 1981-05-21
ZA806871B (en) 1981-10-28
IT8048374A0 (it) 1980-04-09
IE802351L (en) 1981-05-13

Similar Documents

Publication Publication Date Title
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
ES490536A0 (es) Procedimiento para la preparacion de derivados de la glici- namida
ES494635A0 (es) Procedimiento de preparacion de derivados de tiadiazol
ES492891A0 (es) Procedimiento para la preparacion de derivados triyodados deacido 5-amino- isoftalico
NO794317L (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
AR222691A1 (es) Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina
ES491142A0 (es) Procedimiento para la preparacion de derivados de fenileti- lamina
ES493107A0 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
ES491154A0 (es) Procedimiento para la preparacion de derivados furanonicos
MX5215E (es) Procedimiento de preparacion de derivados de tienopiridina
MX6221E (es) Procedimiento para la preparacion de derivados de homoserina
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
ES490999A0 (es) Procedimiento de preparacion de derivados hidroxilicos de isopropilamino-pirimidina
ES494286A0 (es) Procedimiento de preparacion de nuevos derivados 1,1,2-tri- fenilpropanos y -propenos
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
ES491004A0 (es) Procedimiento de preparacion de nuevos derivados halogenadosde isopropilamino-pirimidina
NO801724L (no) Fremgangsmaate for fremstilling av ergopeptin-derivater
AR224518A1 (es) Procedimiento para la preparacion de derivados de 1-piperidino-ftalazina
ES504338A0 (es) Procedimiento de preparacion de derivados difeniletericos
ES497570A0 (es) Procedimiento de preparacion de derivados de ciclopropilani-linas
ES491738A0 (es) Procedimiento de preparacion de trihalogenuros organoestan- nicos
AR220367A1 (es) Procedimiento de preparacion de derivados de la 2-n-bencilidenamino-sulfamoil-benzamida
ES494223A0 (es) Procedimiento para la preparacion de derivados de aroilete- nilpiperidinobutirofenona